The FDA approved a new drug to treat Alzheimer's, but Medicare won't always pay for it – a doctor explains what researchers know about Biogen's Aduhelm
- Written by Andrew Williams, Assistant Professor of Emergency Medicine, Albert Einstein College of Medicine

Medicare finalized its decision to restrict its coverage of Aduhelm, Biogen’s new Alzheimer’s disease drug, on...